scholarly article | Q13442814 |
P356 | DOI | 10.1200/JCO.1995.13.3.603 |
P698 | PubMed publication ID | 7884422 |
P50 | author | Melissa M. Hudson | Q90661800 |
P2093 | author name string | X Luo | |
L E Kun | |||
C B Pratt | |||
L Fang | |||
E I Thompson | |||
J A Wilimas | |||
C Greenwald | |||
O Beaty | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 603-609 | |
P577 | publication date | 1995-03-01 | |
P1433 | published in | Journal of Clinical Oncology | Q400292 |
P1476 | title | Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease | |
P478 | volume | 13 |
Q31926021 | Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2. |
Q62760249 | Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases |
Q74226173 | Breast masses in women treated for childhood cancer: incidence and screening guidelines |
Q44357671 | Breastfeeding in survivors of Hodgkin lymphoma treated with chest radiotherapy |
Q33271477 | Classification tree analysis of second neoplasms in survivors of childhood cancer |
Q36399791 | Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease |
Q32161620 | Early occurrence of a secondary thyroid carcinoma in a child treated for Hodgkin disease. |
Q48342708 | Factors in improved survival from paediatric cancer |
Q92840835 | Fourth malignancy after treatment of Hodgkin's lymphoma: a case report |
Q24792778 | Gene Therapy for Pediatric Cancer: State of the Art and Future Perspectives |
Q37081447 | Genetic profiling differentiates second primary tumors from metastases in adult metachronous soft tissue sarcoma. |
Q41217256 | Hodgkin's disease. Treatment sequelae and quality of life. |
Q36612348 | Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patients |
Q53315385 | International note: second malignant neoplasms in children: a multicenter study of the Polish Pediatric Leukemia/Lymphoma Group. |
Q42526721 | Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease |
Q30432130 | Lymphomas: long-term sequelae and survivorship issues |
Q60171401 | Non-treatment-related chronic myeloid leukemia as a second malignancy |
Q42926964 | Parathyroid Adenoma and Chondrosarcoma After Treatment of Pediatric Hodgkin Disease |
Q35975367 | Radiation associated tumors following therapeutic cranial radiation |
Q30494275 | Radiation-induced leiomyosarcoma: does antimetabolite chemotherapy contribute? A report of three cases |
Q84750153 | Radiation-induced sarcoma in patients with nasopharyngeal carcinoma: a single-institution study |
Q36175987 | Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review |
Q77463889 | Second cancer among long-term survivors from Hodgkin's disease |
Q40720181 | Second malignancy after treatment of childhood acute myeloid leukemia. |
Q44168600 | Second malignant neoplasms in long-term survivors of osteosarcoma: Memorial Sloan-Kettering Cancer Center Experience |
Q36915223 | Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy |
Q34399300 | Second tumours |
Q33392211 | Secondary acute myeloid leukemia after successful treatment for osteosarcoma |
Q50690191 | Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood. |
Q36639305 | Should cancer survivors fear radiation-induced sarcomas? |
Q36491663 | Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose |
Q40821790 | The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease |
Q37078647 | The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium |
Q53790683 | The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience. |
Q80465955 | Time interval to the development of breast carcinoma after treatment for Hodgkin disease |
Q34548570 | Treatment of paediatric Hodgkin's disease. a balance of risks |
Q33822432 | Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy |
Q36493565 | Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease |
Q74066429 | [Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: an analysis of 13 cases] |
Q73471331 | [Male secondary breast cancer after treatment for Hodgkin's disease. Case report and review of the literature] |
Q77356906 | [Radiation-induced sarcoma after breast cancer. Apropos of 8 cases and review of the literature] |
Search more.